Immatics (IMTX) Research & Development (2019 - 2026)
Immatics' Research & Development was -$72.54 million in Q2 2026, compared with -$51.06 million a year earlier.
Powered by 
Analysis
Immatics (IMTX) Research & Development (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immatics' Research & Development was -$254.77 million through Jun 30, 2026; for FY2025, it came in at -$207.7 million.
- In earlier years, Research & Development was -$160.27 million in FY2024, -$128.36 million in FY2023, -$112.54 million in FY2022 and -$103.63 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Research & Development in data going back to Q2 2019.
- Per Business Quant data, IMTX's Research & Development in the three quarters before Q2 2026 was -$69.29 million (Q1 2026), -$57.79 million (Q4 2025) and -$55.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.91 Bn | 1,101.50 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 615.07 Bn | 533.59 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 505.92 Bn | 479.03 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 368.10 Bn | 322.48 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.25 Bn | 262.24 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.76 Bn | 235.45 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.19 Bn | 191.59 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.38 Bn | 164.57 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.37 Bn | 117.02 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Immatics | 952.48 Mn | -1.07 Bn | - | -72.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -72.54 Mn |
| Mar 31, 2026 | -69.29 Mn |
| Dec 31, 2025 | 370.19 Mn |
| Sep 30, 2025 | -55.15 Mn |
| Jun 30, 2025 | -51.06 Mn |
| Mar 31, 2025 | -44.08 Mn |
| Dec 31, 2024 | 271.75 Mn |
| Sep 30, 2024 | -42.73 Mn |
| Jun 30, 2024 | -37.92 Mn |
| Mar 31, 2024 | -34.88 Mn |
| Dec 31, 2023 | 219.56 Mn |
| Sep 30, 2023 | -33.20 Mn |
| Jun 30, 2023 | -29.75 Mn |
| Mar 31, 2023 | -29.60 Mn |
| Dec 31, 2022 | 189.47 Mn |
| Sep 30, 2022 | -28.81 Mn |
| Jun 30, 2022 | -26.91 Mn |
| Mar 31, 2022 | -28.22 Mn |
| Dec 31, 2021 | -26.27 Mn |
| Sep 30, 2021 | -25.03 Mn |
API Access
Immatics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IMTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IMTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IMTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();